Overall, our cross-omics analysis of genetic dependency data from over 1000 cancer cell lines, tumor mRNA expression and prognosis data from the TCGA project, and pharmacologic sensitivity data from more than 800 cancer cell lines indicates CDK7 and CDK9 are putative oncogenic tCDKs acting through diverse mechanisms. This evidence concerns the gene CDK7 and neoplasm.